96 related articles for article (PubMed ID: 9572795)
21. Type II pneumocytes release chemoattractant activity for monocytes constitutively.
Koyama S; Sato E; Nomura H; Kubo K; Nagai S; Izumi T
Am J Physiol; 1997 May; 272(5 Pt 1):L830-7. PubMed ID: 9176245
[TBL] [Abstract][Full Text] [Related]
22. Relative contribution of leukotriene B4 to the neutrophil chemotactic activity produced by the resident human alveolar macrophage.
Martin TR; Raugi G; Merritt TL; Henderson WR
J Clin Invest; 1987 Oct; 80(4):1114-24. PubMed ID: 2821074
[TBL] [Abstract][Full Text] [Related]
23. Methotrexate stimulates lung epithelial cells to release inflammatory cell chemotactic activities.
Koyama S; Sato E; Takamizawa A; Tsukadaira A; Haniuda M; Kurai M; Numanami H; Nagai S; Izumi T
Exp Lung Res; 2003 Mar; 29(2):91-111. PubMed ID: 12554356
[TBL] [Abstract][Full Text] [Related]
24. Bradykinin and substance P potentiate acetylcholine-induced bronchospasm in guinea-pig.
Omini C; Brunelli G; Hernandez A; Daffonchio L
Eur J Pharmacol; 1989 Apr; 163(1):195-7. PubMed ID: 2472966
[TBL] [Abstract][Full Text] [Related]
25. Priming of eosinophil recruitment in vivo by LPS pretreatment.
Macari DM; Teixeira MM; Hellewell PG
J Immunol; 1996 Aug; 157(4):1684-92. PubMed ID: 8759756
[TBL] [Abstract][Full Text] [Related]
26. Eosinophil chemotactic activity in bronchoalveolar lavage fluid obtained from Toxocara canis-infected rats.
Okada K; Fujimoto K; Kubo K; Sekiguchi M; Sugane K
Clin Immunol Immunopathol; 1996 Mar; 78(3):256-62. PubMed ID: 8605701
[TBL] [Abstract][Full Text] [Related]
27. Bronchial epithelial cells release chemotactic activity for lymphocytes.
Robbins RA; Shoji S; Linder J; Gossman GL; Allington LA; Klassen LW; Rennard SI
Am J Physiol; 1989 Aug; 257(2 Pt 1):L109-15. PubMed ID: 2788366
[TBL] [Abstract][Full Text] [Related]
28. A549 cells can express interleukin-16 and stimulate eosinophil chemotaxis.
Cheng G; Ueda T; Eda F; Arima M; Yoshida N; Fukuda T
Am J Respir Cell Mol Biol; 2001 Aug; 25(2):212-8. PubMed ID: 11509331
[TBL] [Abstract][Full Text] [Related]
29. Effects of reactive oxygen and nitrogen metabolites on RANTES- and IL-5-induced eosinophil chemotactic activity in vitro.
Sato E; Simpson KL; Grisham MB; Koyama S; Robbins RA
Am J Pathol; 1999 Aug; 155(2):591-8. PubMed ID: 10433951
[TBL] [Abstract][Full Text] [Related]
30. Identification of a novel and highly potent eosinophil chemotactic lipid in human eosinophils treated with arachidonic acid.
Morita E; Schröder JM; Christophers E
J Immunol; 1990 Mar; 144(5):1893-900. PubMed ID: 2155268
[TBL] [Abstract][Full Text] [Related]
31. Leukotriene B4 mediates substance P-induced granulocyte infiltration into mouse skin. Comparison with antigen-induced granulocyte infiltration.
Iwamoto I; Tomoe S; Tomioka H; Yoshida S
J Immunol; 1993 Aug; 151(4):2116-23. PubMed ID: 7688393
[TBL] [Abstract][Full Text] [Related]
32. Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator.
Liu L; Zuurbier AE; Mul FP; Verhoeven AJ; Lutter R; Knol EF; Roos D
J Immunol; 1998 Sep; 161(6):3064-70. PubMed ID: 9743372
[TBL] [Abstract][Full Text] [Related]
33. The release of eosinophil chemotactic activity and eosinophil chemokinesis inhibitory activity by mononuclear cells from atopic asthmatic and non-atopic subjects.
Grzegorczyk J; Majkowska-Wojciechowska B; Kowalski ML
Mediators Inflamm; 2000; 9(1):7-13. PubMed ID: 10877449
[TBL] [Abstract][Full Text] [Related]
34. Endotoxin stimulates bronchial epithelial cells to release chemotactic factors for neutrophils. A potential mechanism for neutrophil recruitment, cytotoxicity, and inhibition of proliferation in bronchial inflammation.
Koyama S; Rennard SI; Leikauf GD; Shoji S; Von Essen S; Claassen L; Robbins RA
J Immunol; 1991 Dec; 147(12):4293-301. PubMed ID: 1753099
[TBL] [Abstract][Full Text] [Related]
35. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.
Wardlaw AJ; Moqbel R; Cromwell O; Kay AB
J Clin Invest; 1986 Dec; 78(6):1701-6. PubMed ID: 3023451
[TBL] [Abstract][Full Text] [Related]
36. Leukotriene C4 production from human eosinophils in vitro. Role of eosinophil chemotactic factors on eosinophil activation.
Tamura N; Agrawal DK; Townley RG
J Immunol; 1988 Dec; 141(12):4291-7. PubMed ID: 2848892
[TBL] [Abstract][Full Text] [Related]
37. Modulation of acetylcholine release in rabbit airways in vitro.
Colasurdo GN; Loader JE; Graves JP; Larsen GL
Am J Physiol; 1995 Mar; 268(3 Pt 1):L432-7. PubMed ID: 7534996
[TBL] [Abstract][Full Text] [Related]
38. Antiproteases attenuate the release of neutrophil chemotactic activity from bronchial epithelial cells induced by smoke.
Koyama S; Rennard SI; Leikauf GD; Ertl RF; Robbins RA
Exp Lung Res; 1996; 22(1):1-19. PubMed ID: 8838132
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms of aldehyde-induced bronchial reactivity: role of airway epithelium.
Leikauf GD
Res Rep Health Eff Inst; 1992 Feb; (49):1-35. PubMed ID: 1315139
[TBL] [Abstract][Full Text] [Related]
40. Eosinophil chemotaxis inhibited by 5-lipoxygenase blockade and leukotriene receptor antagonism.
Muñoz NM; Douglas I; Mayer D; Herrnreiter A; Zhu X; Leff AR
Am J Respir Crit Care Med; 1997 Apr; 155(4):1398-403. PubMed ID: 9105085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
